Ne47
1 known investors
OpenProtein.AI (ne47.bio) develops protein language and generative AI models for end-to-end protein engineering, including de novo sequence design, variant effect prediction, in silico library screening, and training of specialized models on proprietary data. Its tools are offered to biology and computational research teams through a no-code GUI and programmatic APIs to accelerate design-build-test cycles.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
TB
Tristan Bepler
TF
Timothy F. Truong Jr
Investors Β· 1
Frequently asked questions
- What does Ne47 do?
- OpenProtein.AI (ne47.bio) develops protein language and generative AI models for end-to-end protein engineering, including de novo sequence design, variant effect prediction, in silico library screening, and training of specialized models on proprietary data. Its tools are offered to biology and computational research teams through a no-code GUI and programmatic APIs to accelerate design-build-test cycles.
- Who founded Ne47?
- Ne47 was founded by Tristan Bepler.
- Who are Ne47's investors?
- Ne47's investors include The E14 Fund.